The management of pain in the patient with advanced cancer requires comprehensive assessment and expertise in the application of many therapeutic techniques. Given the complexity of the problems posed by these patients, it is not surprising that most aspects of palliative care derive from personal anecdote and clinical consensus, rather than well-defined guidelines based on research findings. In the absence of such guidelines, unresolved issues and controversies abound. This review discusses some of the most important of these topics, which range from the overall system of care and quality of assessment to the specifics of pharmacotherapy and other modalities of treatment. In so doing, the rationale for some of the accepted clinical approaches can be clarified, others that are as yet little known can be highlighted, and the issues most in need of further investigation can be defined.
Get full access to this article
View all access options for this article.
References
1.
DautRL, CleelandCS. The prevalence and severity of pain in cancer. Cancer1982; 50: 1913–1918.
2.
BonicaJJ. Treatment of cancer pain: current status and future needs. In FieldsHL, DubnerR, CerveroF (eds). Advances in Pain Research and Therapy, Vol. 9. NewYork: Raven Press, 1985: 589–616.
3.
PortenoyRK. Cancer pain: epidemiology and syndromes. Cancer1989; 63: 2298–2307.
4.
World Health Organization. Cancer Pain Relief. Geneva: World Health Organization, 1986.
5.
TwycrossRG, FairfieldS.Pain in far-advanced cancer. Pain1982; 14: 303–310.
6.
ParkesCM. Home or hospital? Terminal care as seen by surviving spouse. J Roy Col Gen Pract1978; 28: 19–30.
7.
Aitken-SwanJ.Nursing the late cancer patient at home. Practitioner1959; 183: 64–69.
8.
MarksRM, SacharEJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med1973; 78: 173–181.
9.
ShineD, DemasP.Knowledge of medical students, residents and attending physicians about opiate abuse. J Med Educ1984; 59: 501–507.
10.
CharapAD. The knowledge, attitudes and experience of medical personnel treating pain in the terminally ill. Mt Sinai J Med1978; 45: 561–580.
11.
KannerRM, PortenoyRK. Unavailability of narcotic analgesics for ambulatory cancer patients in New York City. J Pain Sympt Man1986; 1: 87–90.
12.
PortenoyRK. Practical aspects of pain control in the patient with cancer. CA Cancer Journal for Clinicians1988; 38: 7–32.
13.
CleelandCS, RotondiA, BrechnerT, . A model for the treatment of cancer pain. J Pain Sympt Man1986; 1: 209–216.
14.
FoleyKM, InturrisiCE. Analgesic drug therapy in cancer pain: principles and practice. Med Clin NA1987; 71: 207–232.
15.
TwycrossRG, LackSA. Symptom Control in Far Advanced Cancer: Pain Relief. London: Pittman Publ. Ltd., 1983.
16.
VentafriddaV, TamburiniM, CaraceniA, . A validation study of the WHO method for cancer pain relief. Cancer1987; 59: 850–856.
17.
VentafriddaV, TamburiniM, De ConnoF.Comprehensive treatment in cancer pain. In FieldsHL, DubnerR, CerveroF (eds). Advances in Pain Research and Therapy, vol 9, Proceedings of the Fourth World Congress on Pain. New York: Raven Press, 1985; 617–628.
18.
WalkerVA, HoskinPJ, HanksGW, WhiteID. Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Sympt Man1988; 3: 145–149.
19.
CoyleN.A model of continuity of care for cancer patients with chronic pain. Med Clin NA1987; 71: 259–270.
20.
GonzalezGR, FoleyKM, PortenoyRK. Evaluation skills necessary for a cancer pain consultant. Presented at the American Pain Society meeting, Phoenix, Arizona, Oct 26–29, 1989.
21.
VentafriddaV.Continuing care: a major issue in cancer pain management. Pain1989; 36: 137–144.
22.
ChapmanCR, LoeserJD (eds). Advances in Pain Research and Therapy, Vol. 12, Issues in Pain Measurement. New York: Raven Press, 1989.
23.
DeschampsM, BandPR, ColdmanAJ. Assessment of adult cancer pain: shortcomings of current methods. Pain1988; 32: 133–139.
24.
SpiegelD, BloomJR. Pain in metastatic breast cancer. Cancer1983; 52: 341–345.
25.
FishmanB, HoudeRW, WallensteinS, FoleyKM. Appraisal of pain relief mediates the relationship between pain intensity and emotional distress in cancer pain. Pain Suppl1987; 4: S415.
MorrisJN, MorV, GoldbergRF, . The effect of treatment setting and patient characteristics on pain in terminal cancer patients: a report from the National Hospice Study. J Chronic Dis1986; 39: 27–35.
PadillaGV, FerrellB, GrantMM, RhinerM.Defining the content domain of quality of life for cancer patients with pain. Cancer Nurs, in press.
30.
PortenoyRK. Pain and quality of life: theoretical aspects. In OsobaD (ed). Quality of Life in Cancer Patients. New York: CRC Publ, in press.
31.
PortenoyRK, MaldonadoM, FitzmartinR, KaikoRF, KannerR.Oral controlled-release morphine sulfate: analgesic efficacy and side effects of a 100 mg tablet in cancer pain patients. Cancer1989; 63: 2284–2288.
32.
PasternakGW, BodnarRJ, ClarkJA, InturrisiCE. Morphine–6–glucuronide, a potent mu agonist. Life Sci1987; 41: 2845–2849.
33.
PaulD, StandiferKM, InturrisiCE, PasternakGW. Pharmacological characterization of morphine-6-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther1989; 251: 477–483.
34.
OsborneRJ, JoelSP, TrewD, SlevinML. The analgesic activity of morphine–6–glucuronide. Lancet1988; 1: 828–830.
35.
SaweJ, KagerL, Svensson EngJ-O, RaneA.Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. Br J Clin Pharmacol1985; 19: 495–501.
36.
InturrisiCE, CerboneDJ, ChokshiPH, StulmanJK, PortenoyRK, FoleyKM. Pharmacokinetics and effects of morphine–6–glucuronide after morphine infusions to cancer patients. Presented at the American Pain Society meeting, Phoenix, Arizona, October 26–29, 1989.
37.
OsborneRJ, JoelSP, SlevinML. Morphine intoxication in renal failure: the role of morphine-6-glucuronide. Br Med J1986; 292: 1548–1549.
TwycrossRG. Relief of pain. In SaundersC (ed). The Management of Terminal Malignant Disease. London: Edward Arnold, 1984; 64–90.
40.
SaweJ, HansenJ, GinmanC, . Patient-controlled dose regimen of methadone for chronic cancer pain. Br Med J1981; 282: 771–773.
41.
HanksGW. The pharmacological treatment of bone pain. Cancer Surv1988; 7: 87–101.
42.
SwansonG, SmithJ, BulichR, NewP, ShiffmanR.Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients. J Clin Oncol1989; 7: 1903–1908.
43.
KerrIG, SoneM, DeAngelisC, . Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients. Ann Int Med1988; 108: 554–557.
44.
HoudeRW. Misinformation: side effects and drug interactions. In HillCS, FieldsWS (eds). Advances in Pain Research and Therapy, Vol. 11, Drug Treatment of Cancer Pain in a Drug-Oriented Society. New York: Raven Press, 1989; 145–162.
45.
KaikoRF. Commentary: equianalgesic dose ratio of intramuscular/oral morphine, 1:6 versus 1:3. In FoleyKM, InturrisiCE (eds). Advances in Pain Research and Therapy, vol 8, Opioid Analgesics in the Management of Clinical Pain. New York: Raven Press, 1986; 87–93.
46.
PortenoyRK, MoulinD, RogersA, InturrisiEC, FoleyKM. Continuous intravenous infusion of opioids in cancer pain. Cancer Treat Rep1986; 70: 575–581.
47.
BrueraE, MacMillanD, HansonJ, MacDonaldRN. The Edmonton staging system for cancer pain: preliminary report. Pain1989; 37: 203–210.
48.
CoombsDW. Intraspinal narcotics for intractable cancer pain. In AbramSE (ed). Cancer Pain. Boston: Kluwer Academic Publ., 1988; 77–97.
49.
TwycrossRG. Opioid analgesics in cancer pain: current practice and controversies. Cancer Surv1988; 7: 29–53.
50.
ArnerS, MyersonBA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain1988; 33: 11–23.
51.
HosobuchiY.Analgesia induced by brain stimulation with chronically implanted electrodes. In SchmidekHH, SweetWH (eds). Operative Neurosurgical Techniques. New York: Grune & Stratton, 1982; 981–991.
52.
TwycrossRG, LackSA. Symptom Control in Far Advanced Cancer: Pain Relief. London: Pittman Publ., 1983; 112.
53.
TaskerRR, TsudaT, HawrylyshynP.Clinical neurophysiological investigation of deafferentation pain. In BonicaJJ, LindblomU, IggoA (eds). Advances in Pain Research and Therapy, Vol. 5, Proceedings of the Third World Congress on Pain. New York: Raven Press, 1983; 713–738.
PortenoyRK, FoleyKM. Chronic use of opioid analgesics in nonmalignant pains: report of 38 cases. Pain1986; 25: 171–186.
56.
UrbanBJ, FranceRD, SteinbergerDL, ScottDL, MaltbieAA. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain1986; 24: 191–197.
57.
ForrestW, BrownB, BrownC, . Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med1977; 296: 712–715.
58.
LaskaEM, SunshineA, ZighelboimI, . Effect of caffeine on acetaminophen analgesic. Clin Pharm Ther1983; 33: 498–509.
59.
BrueraE, ChadwickS, BrenneisC, . Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep1987; 71: 67–70.
60.
BrueraE, BrenneisC, PatersonAH, MacDonaldRN. Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Sympt Man1989; 4: 3–6.
61.
BainesM.Nausea and vomiting in the patient with advanced cancer. J Pain Sympt Man1988; 3: 81–86.
62.
VentafriddaV, OliveriE, CaraceniA, . A retrospective study on the use of oral morphine in cancer pain. J Pain Sympt Man1987; 2: 77–81.
63.
FoleyKM. Clinical tolerance. In BasbaumAI, BessonJ-M (eds). Towards a New Pharmacotherapy of Pain:Beyond Morphine. Dahlem Konferenzen. Chichester: John Wiley and Sons, in press.
64.
TwycrossRG. Clinical experience with diamorphine in advanced malignant disease. In J Clin Pharmacol Ther1974; 9: 184–198.
65.
KannerRM, FoleyKM. Patterns of narcotic drug use in a cancer pain clinic. Ann NY Acad Sci1981; 362: 161–172.
66.
DoleVP. Narcotic addiction, physical dependence and relapse. N Engl J Med1972; 286: 988–992.
67.
RinaldiRC, SteindlerEM, WilfordBB, GoodwinD.Clarification and standardization of substance abuse terminology. JAMA1988; 259: 555–557.
68.
JaffeJH. Drug addiction and drug abuse. In GilmanAG, GoodmanLS, RallTW, MuradF (eds). The Pharmacological Basis of Therapeutics, 7th Ed. NewYork: Macmillan Publishing Co., 1985; 532–581.
